| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 869 | 751 | 46 |
| Full Text Views | 84 | 2 | 0 |
| PDF Downloads | 25 | 2 | 0 |
An intranasal challenge model for testing Japanese encephalitis vaccines in rhesus monkeys.
B Raengsakulrach
B Raengsakulrach
Department of Virology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
Search for other papers by B Raengsakulrach in
Current site
Google Scholar
PubMed
Search for other papers by B Raengsakulrach in
Current site
Google Scholar
PubMed
A Nisalak
A Nisalak
Department of Virology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
Search for other papers by A Nisalak in
Current site
Google Scholar
PubMed
Search for other papers by A Nisalak in
Current site
Google Scholar
PubMed
M Gettayacamin
M Gettayacamin
Department of Virology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
Search for other papers by M Gettayacamin in
Current site
Google Scholar
PubMed
Search for other papers by M Gettayacamin in
Current site
Google Scholar
PubMed
V Thirawuth
V Thirawuth
Department of Virology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
Search for other papers by V Thirawuth in
Current site
Google Scholar
PubMed
Search for other papers by V Thirawuth in
Current site
Google Scholar
PubMed
G D Young
G D Young
Department of Virology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
Search for other papers by G D Young in
Current site
Google Scholar
PubMed
Search for other papers by G D Young in
Current site
Google Scholar
PubMed
K S Myint
K S Myint
Department of Virology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
Search for other papers by K S Myint in
Current site
Google Scholar
PubMed
Search for other papers by K S Myint in
Current site
Google Scholar
PubMed
L M Ferguson
L M Ferguson
Department of Virology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
Search for other papers by L M Ferguson in
Current site
Google Scholar
PubMed
Search for other papers by L M Ferguson in
Current site
Google Scholar
PubMed
C H Hoke Jr
C H Hoke Jr
Department of Virology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
Search for other papers by C H Hoke Jr in
Current site
Google Scholar
PubMed
Search for other papers by C H Hoke Jr in
Current site
Google Scholar
PubMed
B L Innis
B L Innis
Department of Virology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
Search for other papers by B L Innis in
Current site
Google Scholar
PubMed
Search for other papers by B L Innis in
Current site
Google Scholar
PubMed
D W Vaughn
D W Vaughn
Department of Virology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
Search for other papers by D W Vaughn in
Current site
Google Scholar
PubMed
Search for other papers by D W Vaughn in
Current site
Google Scholar
PubMed
Placebo-controlled field efficacy trials of new Japanese encephalitis (JE) vaccines may be impractical. Therefore, an animal model to evaluate efficacy of candidate JE vaccines is sought. Previous work has shown that exposure of monkeys to JE virus (JEV) via the intranasal route results in encephalitis. Here we report the further development of this model and the availability of titered virus stocks to assess the protective efficacy of JE vaccines. To determine the effective dose of our JE challenge virus, dilutions of a stock JEV (KE-93 isolate) were inoculated into four groups of three rhesus monkeys. A dose-dependent response was observed and the 50% effective dose (ED50) was determined to be 6.0 x 10(7) plaque forming units (pfu). Among animals that developed encephalitis, clinical signs occurred 9-14 days postinoculation. Infection with JEV was confirmed by detection of JEV in nervous tissues and IgM to JEV in the cerebrospinal fluid. Viremia with JEV was also detected intermittently throughout infection. Validation of the model was performed using a known effective JE vaccine and saline control. One ED90 of virus (2.0 x 10(9) pfu) was used as a challenge dose. Four of four animals that received saline control developed encephalitis while one of four monkeys administered the JE vaccine did so. This study demonstrates that the virus strain, route of inoculation, dose, and the outcome measure (encephalitis) are suitable for assessment of protective efficacy of candidate JE vaccines.
Author Notes
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 869 | 751 | 46 |
| Full Text Views | 84 | 2 | 0 |
| PDF Downloads | 25 | 2 | 0 |